Signify Health, Inc.
SGFY · NYSE
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $203 | $140 | $246 | $217 |
| % Growth | 45.2% | -43.2% | 13.7% | – |
| Cost of Goods Sold | $75 | $123 | $128 | $115 |
| Gross Profit | $128 | $17 | $119 | $102 |
| % Margin | 63.1% | 11.8% | 48.1% | 47.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | -$11 | $59 | $84 | $70 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $15 | $20 | $18 |
| Operating Expenses | -$10 | $73 | $105 | $88 |
| Operating Income | $126 | -$57 | $41 | -$15 |
| % Margin | 61.9% | -40.6% | 16.8% | -7% |
| Other Income/Exp. Net | $382 | -$217 | -$526 | -$33 |
| Pre-Tax Income | $644 | -$274 | -$485 | -$22 |
| Tax Expense | $43 | -$49 | $5 | -$6 |
| Net Income | $601 | -$225 | -$490 | -$16 |
| % Margin | 296% | -160.9% | -199% | -7.5% |
| EPS | 3.41 | -1.27 | -2.78 | -0.094 |
| % Growth | 368.5% | 54.3% | -2,848% | – |
| EPS Diluted | 3.41 | -1.27 | -2.78 | -0.094 |
| Weighted Avg Shares Out | 176 | 177 | 176 | 173 |
| Weighted Avg Shares Out Dil | 176 | 177 | 176 | 173 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6 | $6 | $5 | $4 |
| Depreciation & Amortization | $0 | -$164 | $22 | $20 |
| EBITDA | $126 | -$221 | $91 | $5 |
| % Margin | 62% | -157.8% | 36.8% | 2.1% |